Hormone Therapy May Cut Colorectal Cancer Risk
A new study released by the American Association for Cancer Research in the latest issue of Cancer Epidemiology, Biomarkers and Prevention, details that hormone replacement therapy could reduce the risk of developing colorectal cancer.
A new study released by the American Association for Cancer Research in the latest issue of Cancer Epidemiology, Biomarkers and Prevention, details that hormone replacement therapy could reduce the risk of developing colorectal cancer. The research shows that there was a risk reduction of 48 percent in women that used a combination treatment of estrogen plus progestin as a hormone regimen for two to five years. The research involved over 56,000 women who were followed for a span of 15 years. Among the 56,000-plus women that were followed, only 960 of them were diagnosed with colorectal cancer.
The first interviews of the study were conducted from 1979 to 1981 and the average age at the start of those interviews was 55.7. Users of estrogen plus progestin that stopped the treatments five years ago were found to have a 45 percent risk reduction of developing colorectal cancer. For any individual that has been diagnosed with cancer, contact the law offices of Michael Gunzburg for expert legal counsel today.
